Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000848

Drug Information
SynonymsSocian; Amisulpridum [INN-Latin]; Amisulprida [INN-Spanish]; Solian (TN); NCGC00092310-02; MLS001424039; 4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-anisamid; MLS000758258; D07310; SAM001246639; NCGC00092310-04; CPD000449309; SAM001246966; A2729_SIGMA; MLS000759450; S1280_Selleck; 4-Amino-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-(ethylsulfonyl)-2-methoxybenzamide; C17H27N3O4S; STK635172; HMS2051K10; Benzamide, 4-amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxy-; Deniban; Amisulprida; SL-91.1077; Amisulpridum; LS-25532; Amisulpiride; Deniban (TN); DAN 2163; 4-amino-N-[(1-ethylpyrrolidin-2-yl)methyl]-5-(ethylsulfonyl)-2-methoxybenzamide; amisulpride; CID2159; L000106; SMR000449309; Bio-0114; CHEMBL243712; Solian, Amisulpride; Aminosultopride; MolPort-003-983-463; 4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-o-anisamide; Solian; Amisulpride (INN); 71675-85-9; EINECS 275-831-7; NCGC00092310-01; AC-6820; 4-amino-N-[(1-ethylpyrrolidin-2-yl)methyl]-5-ethylsulfonyl-2-methoxybenzamide; I06-0334; Amisulpride [INN]; DB06288; DAN-2163; 4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide; AC1L1D1X; BRD-A60197193-001-05-4    
Trade NameSolian    
IndicationSchizophreniaApproved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassAntipsychotic Agents    
CAS NumberCAS 53583-79-2
PubChem Compound IDCID 2159.    
PubChem Substance IDSID 211061.    
SuperDrug ATC IDN05AL05;    
SuperDrug CAS ID071675859;    
TargetD(2) dopamine receptorAntagonist[2][3][4]
Ref 1Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. To Reference
Ref 2Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia. CNS Drugs. 2006;20(5):389-409. To Reference
Ref 3Amisulpride: a review of its use in the management of schizophrenia. CNS Drugs. 2004;18(13):933-56. To Reference
Ref 4Atypical antipsychotics: mechanism of action. Can J Psychiatry. 2002 Feb;47(1):27-38. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543